On January 20, 2025, Anhui Daily released a video titled Green Food Northern Anhui Tour | [One Cattle "Leads" the Whole Industry Chain], highlighting GENOMBIO’s outstanding achievements in fetal bovine serum-related products. The report comprehensively showcased how Lixin County—a major cattle-raising region—drives industrial upgrading through technological innovation. Behind this lies the relentless efforts of Genom Biopharmaceutical Technology (Anhui) Co., Ltd. in advancing technological innovation and industrial development.
On December 26, 2024, Tang Jianjun, Executive President of the Cattle Branch of the China Animal Agriculture Association, led a delegation to visit Genom Biopharmaceutical Technology (Anhui) Co., Ltd. Accompanied by Jiao Peng, Member of the Standing Committee of the Lixin County CPC Committee and Deputy County Governor, and Guo Quande, Director of the Lixin Economic Development Zone, the delegation aimed to gain in-depth insights into GENOMBIO’s innovations in biopharmaceuticals and their contributions to local economic growth.
Dr. Li Liang, Chairman and President of GENOMBIO, detailed the company’s developmental journey since its inception, emphasizing how technological innovation enhances the added value of the beef cattle industry. Leveraging long-term expertise and breakthroughs in cell biology, gene editing, and regenerative medicine, GENOMBIO has developed a series of high-value-added products and services, including stem cell therapies, functional foods, and health supplements. These innovations significantly elevate the value chain of the beef cattle sector, injecting new vitality into traditional animal husbandry.
GENOMBIO not only focuses on R&D and production within biopharmaceuticals but also actively contributes to local economic development. With a total investment of approximately ¥120 million for Phase I, the project commenced construction in August 2023 and is expected to be fully operational by March 2025. Facilities include GMP workshops and high-standard P2-level laboratories, which will inject robust momentum into Lixin County’s economy. Additionally, the company has established multiple joint R&D centers covering areas such as Matrigel, cell culture media, and animal blood products, creating more job opportunities and economic growth points for the region.
The release of Anhui Daily’s video Green Food Northern Anhui Tour | [One Cattle "Leads" the Whole Industry Chain], along with its coverage of GENOMBIO’s fetal bovine serum products, further elevated the brand’s influence. The video highlighted Lixin County’s status as a major cattle-raising hub, with 73,100 beef cattle slaughtered in 2024, a standing inventory of 92,500 head, and a total inventory of 165,600 head—all ranking among the highest in the province. In recent years, Lixin County has actively strengthened its beef cattle industry by building the "Anhui Beef" brand, extending the industrial chain, and enhancing value chains, achieving rural revitalization and industrial prosperity.
The inspection not only affirmed GENOMBIO’s achievements in recent years but also inspired its future development. GENOMBIO will continue to leverage technological innovation as its core driving force, exploring new technologies and products to contribute to the high-quality development of China’s biopharmaceutical industry. Simultaneously, the company will remain actively engaged in local economic development, supporting the upgrade of traditional industries and making greater contributions to the "Healthy China 2030" initiative and rural revitalization strategy.
GENOMBIO’s story is a vivid case study of how technological power transforms traditional industries, drives local economic prosperity, and advances social progress. Moving forward, GENOMBIO will join hands with more partners to open a new chapter of brilliance.